Shoulder Innovations (NYSE:SI) COO Matthew Fraser Ahearn Sells 8,314 Shares of Stock

Shoulder Innovations, Inc. (NYSE:SI) COO Matthew Fraser Ahearn sold 8,314 shares of Shoulder Innovations stock in a transaction on Monday, August 17th. The shares were sold at an average price of $20.10, for a total transaction of $167,111.40. Following the completion of the transaction, the chief operating officer directly owned 258,362 shares of the company’s stock, valued at $5,193,076.20. The trade was a 3.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

• On Tuesday, August 18th, Matthew Fraser Ahearn sold 14,186 shares of Shoulder Innovations stock. The stock was sold at an average price of $20.99, for a total transaction of $297,764.14.
• On Monday, June 15th, Matthew Fraser Ahearn sold 4,144 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.84, for a total value of $78,072.96.
• On Friday, June 12th, Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.68, for a total value of $296,190.08.

Shoulder Innovations Price Performance

NYSE SI traded up $1.17 during trading hours on Tuesday, reaching $21.09. The company’s stock had a trading volume of 127,644 shares, compared to its average volume of 95,374. The firm has a market capitalization of $439.14 million and a price-to-earnings ratio of -10.99. The company’s 50-day moving average is $20.60 and its two-hundred day moving average is $16.32. The company has a debt-to-equity ratio of 0.12, a current ratio of 10.71 and a quick ratio of 8.92. Shoulder Innovations, Inc. has a 1-year low of $10.92 and a 1-year high of $24.59.

Shoulder Innovations (NYSE:SI) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). The business had revenue of $17.18 million during the quarter. Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. On average, equities analysts predict that Shoulder Innovations, Inc. will post -1.9 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on SI. Weiss Ratings upgraded shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 3rd. UBS Group lifted their target price on shares of Shoulder Innovations from $27.00 to $28.00 and gave the company a “buy” rating in a research report on Monday, August 10th. BTIG Research boosted their target price on shares of Shoulder Innovations from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a research note on Friday, August 7th. Six analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $23.50.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SI. Deerfield Management Company L.P. acquired a new stake in Shoulder Innovations during the 3rd quarter worth $6,056,000. Alyeska Investment Group L.P. purchased a new position in shares of Shoulder Innovations in the third quarter worth about $5,667,000. Vanguard Group Inc. purchased a new position in shares of Shoulder Innovations in the third quarter worth about $1,836,000. Roubaix Capital LLC boosted its position in Shoulder Innovations by 61.9% during the first quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after acquiring an additional 98,305 shares during the last quarter. Finally, Millennium Management LLC purchased a new stake in Shoulder Innovations during the 4th quarter valued at about $1,316,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.